<- Go Home

Imricor Medical Systems, Inc.

Imricor Medical Systems, Inc., a medical device company, designs, manufactures, sells, and distributes magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures in the United States, Europe, and the Middle East. The company’s products include Vision-MR Ablation Catheter 2.0, a MR-compatible cardiac ablation catheter; Vision-MR Diagnostic Catheter, a MR-compatible diagnostic catheter; NorthStar mapping system, a real-time, high-resolution soft tissue imaging of MRI to guide and visualize procedures with exceptional clarity; and Advantage-MR EP Recorder / Stimulator. It also offers Vision-MR Dispersive Electrode to minimize eddy currents induced on the device’s conductive pads during mr scanning. Imricor Medical Systems, Inc. was incorporated in 2006 and is headquartered in Burnsville, Minnesota.

Market Cap

AUD 457.2M

Volume

312.0K

Cash and Equivalents

AUD 19.5M

EBITDA

-AUD 22.0M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

-AUD 2.0M

Profit Margin

695.68%

52 Week High

AUD 1.60

52 Week Low

AUD 0.82

Dividend

N/A

Price / Book Value

36.03

Price / Earnings

-15.78

Price / Tangible Book Value

36.03

Enterprise Value

AUD 442.4M

Enterprise Value / EBITDA

-20.49

Operating Income

-AUD 22.8M

Return on Equity

1221.27%

Return on Assets

-42.28

Cash and Short Term Investments

AUD 40.8M

Debt

AUD 26.0M

Equity

AUD 11.5M

Revenue

AUD 292.3K

Unlevered FCF

-AUD 9.2M

Sector

Health Care Equipment and Supplies

Category

N/A

Company Stock Pitches